Peter Werth
Directeur/Membre du Conseil chez ALOPEXX, INC.
Fortune : 988 695 $ au 30/04/2024
Profil
Peter J.
Werth is the founder of Chemwerth, Inc. (founded in 1982) and currently holds the position of President & Chief Executive Officer.
He is also the founder of The Werth Family Foundation, Inc. Mr. Werth's current jobs include being a Director at Cingulate Therapeutics LLC (since 2018), SciDose LLC, Altos Therapeutics LLC (since 2012), VM Pharma LLC (since 2010), Nuance Designs of CT LLC (since 2015), Alzeca Biosciences, Inc. (since 2017), MedRhythms, Inc. (since 2018), Likarda LLC (since 2017), Cingulate Works, Inc. (since 2018), VM Oncology LLC (since 2014), Perseus Science Group LLC (since 2015), Cingulate, Inc., Alopexx Vaccines LLC (since 2012), Alopexx, Inc., VM Therapeutics LLC (since 2012), and Werth Family Investment Associates LLC.
Mr. Werth's former jobs include being a Director at InnoPharma, Inc., a Research & Development Officer at Pfizer Inc. (from 1965 to 1975), and Vice President-Sales & Marketing at Ganes Chemicals, Inc. (from 1975 to 1982).
Mr. Werth's education includes a graduate degree from Stanford University, and undergraduate degrees from Fort Hays State University and Kansas State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CINGULATE, INC.
29,59% | 15/04/2024 | 1 177 018 ( 29,59% ) | 988 695 $ | 30/04/2024 |
Postes actifs de Peter Werth
| Sociétés | Poste | Début |
|---|---|---|
| CINGULATE INC. | Directeur/Membre du Conseil | 01/06/2018 |
| ALOPEXX, INC. | Directeur/Membre du Conseil | - |
Chemwerth, Inc.
 Chemwerth, Inc. Pharmaceuticals: MajorHealth Technology Chemwerth, Inc. develops and supplies pharmaceutical products. The company offers oral, injectable, veterinary, oncology, topical, investigational stage, and in development stage products. It also offers a range of services, including regulatory affairs and technical service department, as well as customs clearance and logistics support services. The company was founded by Peter J. Werth Jr in 1982 and is headquartered in Woodbridge, CT. | Directeur Général | 30/09/2009 |
| VM Therapeutics LLC | Directeur/Membre du Conseil | 01/05/2012 |
| Alopexx Vaccines LLC | Directeur/Membre du Conseil | 01/06/2012 |
Likarda LLC
 Likarda LLC Miscellaneous Commercial ServicesCommercial Services Likarda LLC is a cell therapy company that develops enabling technologies to improve the efficacy of cell therapies and provide sustainable reversal for chronic or fatal diseases. The private company's core technology is the core-shell spherification (CSS) technology, which coats cells and biologics with inert hydrogels to ensure they remain at their intended target location within the body and are shielded from potential degradation. Likarda is based in Cambridge, MA. This customizable platform is pivotal in maintaining cell viability and optimizing the delivery of biologics. | Directeur/Membre du Conseil | 01/08/2017 |
| Perseus Science Group LLC | Directeur/Membre du Conseil | 01/01/2015 |
Nuance Designs of CT LLC
 Nuance Designs of CT LLC Medical SpecialtiesHealth Technology Nuance Designs of CT LLC is a private company that specializes in designing and developing auto-injectors and self-injection devices. The company is based in Woodbridge, CT. | Directeur/Membre du Conseil | 01/01/2015 |
| VM Oncology LLC | Directeur/Membre du Conseil | 01/08/2014 |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Peter Werth
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Peter Werth
| Stanford University | Graduate Degree |
| Kansas State University | Undergraduate Degree |
| Fort Hays State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| CINGULATE INC. | Health Technology |
| Entreprise privées | 19 |
|---|---|
Chemwerth, Inc.
Chemwerth, Inc. Pharmaceuticals: MajorHealth Technology Chemwerth, Inc. develops and supplies pharmaceutical products. The company offers oral, injectable, veterinary, oncology, topical, investigational stage, and in development stage products. It also offers a range of services, including regulatory affairs and technical service department, as well as customs clearance and logistics support services. The company was founded by Peter J. Werth Jr in 1982 and is headquartered in Woodbridge, CT. | Health Technology |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| SciDose LLC | |
InnoPharma, Inc.
 InnoPharma, Inc. Pharmaceuticals: MajorHealth Technology InnoPharma, Inc. provides pharma drugs. The firm is a developer of sterile generic and specialty pharmaceutical products. It works with manufacturing and clinical research organizations worldwide for commercialization of its developed products. The company was founded by Navneet Puri and Sriram J. Ramanathan in 2005 and is headquartered in Piscataway, NJ. | Health Technology |
| The Werth Family Foundation, Inc. | |
Alzeca Biosciences, Inc.
 Alzeca Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici. | Commercial Services |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
MedRhythms, Inc.
 MedRhythms, Inc. Medical/Nursing ServicesHealth Services MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then. | Health Services |
| Ganes Chemicals, Inc. | |
VM Pharma LLC
 VM Pharma LLC Medical SpecialtiesHealth Technology VM Pharma LLC develops and identifies allosteric kinase inhibitors. The firm specializes in the treatment of pain, cancer, and other human diseases. The company is headquartered in Fremont, CA. | Health Technology |
| Altos Therapeutics LLC | |
| VM Oncology LLC | |
Nuance Designs of CT LLC
Nuance Designs of CT LLC Medical SpecialtiesHealth Technology Nuance Designs of CT LLC is a private company that specializes in designing and developing auto-injectors and self-injection devices. The company is based in Woodbridge, CT. | Health Technology |
| Perseus Science Group LLC | |
Likarda LLC
Likarda LLC Miscellaneous Commercial ServicesCommercial Services Likarda LLC is a cell therapy company that develops enabling technologies to improve the efficacy of cell therapies and provide sustainable reversal for chronic or fatal diseases. The private company's core technology is the core-shell spherification (CSS) technology, which coats cells and biologics with inert hydrogels to ensure they remain at their intended target location within the body and are shielded from potential degradation. Likarda is based in Cambridge, MA. This customizable platform is pivotal in maintaining cell viability and optimizing the delivery of biologics. | Commercial Services |
| Alopexx Vaccines LLC | |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
| VM Therapeutics LLC | |
| Werth Family Investment Associates LLC | Finance |
